Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis

Risk-stratifying patients with hepatitis C virus (HCV) cirrhosis according to medium-term prognosis will inform clinical decision-making. It is unclear which biomarkers/models are optimal for this purpose. We quantified the discriminative ability of 14 diverse biomarkers for prognosis prediction ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Innes, Hamish, Walker, Alex J., Benselin, Jennifer, Grove, Jane I., Pedergnana, Vincent, Azim Ansari, M., Lin, Shang-Kuan, McLauchlan, John, Hutchinson, Sharon J., Barnes, Eleanor, Irving, William L., Guha, Indra Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963831/
https://www.ncbi.nlm.nih.gov/pubmed/35142723
http://dx.doi.org/10.14309/ctg.0000000000000462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963831/
https://www.ncbi.nlm.nih.gov/pubmed/35142723
http://dx.doi.org/10.14309/ctg.0000000000000462

Ejemplares similares